Ticker Update
AstraZeneca (AZN) Stock Fell 10% While Alexion (ALXN) Stock Rose 27% Since Acquisition Deal News
Biotech firm AstraZeneca plc (AZN) recently announced the acquisition of biotech company Alexion Pharmaceuticals (ALXN) on Saturday 12 December. The announced transaction was large as it was worth $39 billion and that also entails a substantial premium for shareholders of Alexion. AstraZeneca has just signed
